- CRISPR/Cas9-Editing-Based Modeling of Tumor Hypoxia
Neha Masarkar et al, 2023, Hypoxia in Cancer: Significance and Impact on Cancer Therapy CrossRef - CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review
Fatima Akram et al, 2020, Protein & Peptide Letters CrossRef - CRISPR based therapeutics: a new paradigm in cancer precision medicine
Sumit Das et al, 2022, Molecular Cancer CrossRef - RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?
Kurt Sartorius et al, 2022, Frontiers in Oncology CrossRef - Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy
Emanuela Stampone et al, 2023, Cellular and Molecular Life Sciences CrossRef - CRISPR/Cas gene editing and delivery systems for cancer therapy
Yingjie Li et al, 2024, WIREs Nanomedicine and Nanobiotechnology CrossRef - A Three-Gene Signature for Predicting the Prognosis of Patients Treated with Transarterial Chemoembolization (TACE) and Identification of PD-184352 as a Potential Drug to Reverse Nonresponse to TACE
Zicong Xia et al, 2022, Journal of Oncology CrossRef - CRISPR/Cas systems: Delivery and application in gene therapy
Jie Huang et al, 2022, Frontiers in Bioengineering and Biotechnology CrossRef